3,4,5-Trimethoxyamphetamine
A psychoactive drug of the phenethylamine and amphetamine chemical classes
| 3,4,5-Trimethoxyamphetamine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Uncontrolled |
| CAS Number | 2234-16-4 |
| PubChem | 4446 |
| DrugBank | |
| ChemSpider | 4291 |
| KEGG | |
3,4,5-Trimethoxyamphetamine (TMA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes. It is known for its hallucinogenic effects and is structurally related to other psychedelic compounds such as mescaline.
Chemical structure and properties
3,4,5-Trimethoxyamphetamine is a substituted amphetamine, characterized by the presence of three methoxy groups attached to the benzene ring of the amphetamine backbone. The chemical formula is C12H19NO3, and it has a molecular weight of 225.29 g/mol.
Pharmacology
TMA acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound also has affinity for other serotonin receptors, contributing to its overall psychoactive profile.
Effects
The effects of 3,4,5-Trimethoxyamphetamine are similar to those of other psychedelic drugs, including altered perception, mood, and cognition. Users may experience visual hallucinations, changes in thought patterns, and an altered sense of time. The intensity and duration of effects can vary based on dosage and individual sensitivity.
History and usage
TMA was first synthesized by the chemist Alexander Shulgin, who documented its effects in his book PiHKAL: A Chemical Love Story. It has been used primarily in research settings to study the effects of psychedelics on the human mind.
Legal status
3,4,5-Trimethoxyamphetamine is not a controlled substance in many countries, but its legal status can vary. It is important to check local regulations before acquiring or using this compound.
Related compounds
See also
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian